annual meeting program - American Society of Clinical Oncology

8:00 AM - 12:00 PM
GENERAL POSTER SESSION
Saturday, June 5, 2010
Cancer Prevention/Epidemiology
Location: S Hall A2
Tracks(s): Cancer Prevention/Epidemiology
Brd. 1A High prevalence of BRCA1/2 germline mutations in female breast cancer
patients with triple-negative phenotype (TNBC) and family history. (Abstract
#1534)
C. Saura, G. Sánchez-Ollé, N. Bosch, N. Gadea, M. Masas, A. Tenes,
S. Gutierrez-Enríquez, O. Díez, J. Baselga, J. Balmaña
Brd. 1B Prospective screening for Lynch syndrome (LS) in a cohort of colorectal
cancer (CRC) surgical patients in a community hospital. (Abstract #1535)
P. R. Duncan, J. T. Lin, R. Feddersen
Brd. 1C Effect of BRCA1 gene and estrogen-receptor � on regulation of serum
estradiol levels in women with breast cancer. (Abstract #1536)
J. Kim, S. Lee, K. H. Oktay
Brd. 1D Association of death receptor 4 variant (Glu228Ala) with ovarian cancer risk
in BRCA1-mutation carriers. (Abstract #1537)
M. G. Dick, B. Versmold, C. Engel, C. Sutter, R. K. Schmutzler, German
Consortium for Hereditary Breast and Ovarian Cancer (GCHBOC)
Brd. 1E Breast cancer gene expression profile in young women who are noncarriers
of BRCA1/2 mutations with and without familial history. (Abstract #1538)
D. M. Carraro, C. A. Moreira-Filho, P. L. Ramos, B. C. Lisboa, H. Brentani,
M. W. Achatz, M. A. Koike Folgueira, M. H. Katayama, M. Brentani
Brd. 1F Publication bias in translational research and number of polymorphisms
analyzed in genetic association studies. (Abstract #1539)
L. Tsali, A. Valachis, C. Neophytou, N. P. Polyzos, S. Drachtidi, L. Tsilidou,
E. E. Skamagouli, V. Paparoupa, D. Mauri
Brd. 1G MUTYH gene mutations in Spanish individuals with multiple colorectal
adenomas without APC gene mutation. (Abstract #1540)
A. I. Ferrer, M. Strunk, R. Andres, A. Ferrandez, A. Alonso, M. Fernandez, A. Tres,
J. Godino
Brd. 1H Association between XRCC1 gene haplotype tagging single nucleotide
polymorphisms and non-small cell lung cancer in Korean patients. (Abstract
#1541)
G. Lee, I. Kim, D. Kim, S. Kim, H. Kim, J. Kang, S. Oh
Brd. 2A Mutation position in BRCA-associated breast cancers. (Abstract #1542)
F. Meric-Bernstam, A. Gutierrez-Barrera, J. K. Litton, L. Mellor-Crummey,
K. Ready, A. M. Gonzalez-Angulo, K. H. Lu, G. N. Hortobagyi, B. Arun
Brd. 2B Association of HER2 655 ile3Val polymorphism with pathological response
to neoadjuvant chemotherapy and trastuzumab in breast cancer. (Abstract
#1543)
A. M. Astorga
Brd. 2C Is lobular breast cancer mainly inherited from the father? (Abstract #1544)
H. L. Olsson, C. Ellberg
Brd. 2D Gene expression profiles in non-small cell lung cancers (NSCLCs) and in
corresponding healthy lung tissues in smokers versus nonsmokers.
(Abstract #1545)
A. Szymanowska-Narloch, M. Skrzypski, M. Taron, H. Dienemann, W. Rzyman,
M. Jarzab, T. Muley, E. Jassem, R. Rosell, J. Jassem
Brd. 2E Pilot program of fast-track germline genetic analyses as part of integrated
breast, ovarian, or gastrointestinal personalized cancer care program.
(Abstract #1546)
O. Caron, B. Bressac-de-Paillerets, D. Malka, A. Remenieras, C. Bourgier,
C. Uzan, M. Spielmann, M. Blayau, T. Frébourg, S. Delaloge
87
SATURDAY